Editorial: Advances in Autoimmune Myasthenia Gravis.
作者信息
Punga Anna Rostedt, Kusner Linda, Berrih-Aknin Sonia, Le Panse Rozen
机构信息
Department of Neuroscience, Clinical Neurophysiology, Uppsala University, Uppsala, Sweden.
Department of Pharmacology and Physiology, The George Washington University, Washington, DC, United States.
出版信息
Front Immunol. 2020 Aug 28;11:1688. doi: 10.3389/fimmu.2020.01688. eCollection 2020.
Abstract
摘要
相似文献
1
Editorial: Advances in Autoimmune Myasthenia Gravis.社论：自身免疫性重症肌无力的进展
Front Immunol. 2020 Aug 28;11:1688. doi: 10.3389/fimmu.2020.01688. eCollection 2020.
2
Complicating autoimmune diseases in myasthenia gravis: a review.重症肌无力合并自身免疫性疾病：综述
Autoimmunity. 2015;48(6):362-8. doi: 10.3109/08916934.2015.1030614. Epub 2015 Apr 27.
3
[Seronegative myasthenia gravis].[血清阴性重症肌无力]
Med Sci (Paris). 2017 Nov;33 Hors série n°1:34-38. doi: 10.1051/medsci/201733s107. Epub 2017 Nov 15.
4
Severe myasthenia gravis with anti-LRP4 antibodies and Hodgkin lymphoma.
Muscle Nerve. 2021 Jan;63(1):E2-E4. doi: 10.1002/mus.27079. Epub 2020 Oct 26.
5
MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.乙酰胆碱受体抗体血清阳性重症肌无力与乙酰胆碱受体抗体血清阴性重症肌无力中的肌肉特异性激酶抗体
Neurology. 2004 Jun 8;62(11):2132-3. doi: 10.1212/01.wnl.0000129274.12702.92.
6
Two sisters with anti-MuSK-positive myasthenia gravis.两名患有抗肌肉特异性激酶（MuSK）阳性重症肌无力的姐妹。
Clin Neurol Neurosurg. 2019 Jul;182:17-18. doi: 10.1016/j.clineuro.2019.04.011. Epub 2019 Apr 21.
7
Mantle cell lymphoma and anti-MuSK-positive Myasthenia gravis.套细胞淋巴瘤与抗肌肉特异性激酶阳性重症肌无力
Onkologie. 2011;34(7):382-3. doi: 10.1159/000329610. Epub 2011 Jun 17.
8
Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients.利妥昔单抗对MuSK自身抗体型重症肌无力患者的长期益处。
J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1407-9. doi: 10.1136/jnnp-2012-303664. Epub 2013 Jun 12.
9
Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.肌肉特异性受体酪氨酸激酶（MuSK）重症肌无力。
Curr Neurol Neurosci Rep. 2016 Jul;16(7):61. doi: 10.1007/s11910-016-0668-z.
10
Rituximab in the treatment of MuSK antibody-positive myasthenia gravis.利妥昔单抗治疗肌肉特异性激酶（MuSK）抗体阳性的重症肌无力
J Clin Neuromuscul Dis. 2011 Mar;12(3):163-4. doi: 10.1097/CND.0b013e3181df2b3e.
引用本文的文献
1
Inflammatory imbalance and activation deficits in T cells of myasthenia gravis patients revealed by proteomic profiling.蛋白质组学分析揭示重症肌无力患者T细胞中的炎症失衡与激活缺陷
Front Immunol. 2025 Aug 4;16:1648020. doi: 10.3389/fimmu.2025.1648020. eCollection 2025.
2
Case report: A co-existing case of ulcerative colitis and dysferlinopathy in a male patient.病例报告：一名男性患者同时患有溃疡性结肠炎和dysferlinopathy（一种遗传性肌肉疾病，暂译为“dysferlin病”）。
Front Med (Lausanne). 2025 Jan 22;11:1481780. doi: 10.3389/fmed.2024.1481780. eCollection 2024.
3
Editorial: Global excellence in inflammatory diseases: North America 2021.社论：2021年北美地区在炎症性疾病领域的全球卓越表现
Front Immunol. 2023 Jul 6;14:1245827. doi: 10.3389/fimmu.2023.1245827. eCollection 2023.
4
Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis.眼肌型重症肌无力与全身型重症肌无力外周血调节性T细胞及其功能亚群的比较
Front Med (Lausanne). 2022 Jun 9;9:851808. doi: 10.3389/fmed.2022.851808. eCollection 2022.
本文引用的文献
1
Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis.T 滤泡辅助细胞产生白细胞介素-17 的失衡促进 MuSK 抗体阳性重症肌无力的促炎反应。
J Neuroimmunol. 2020 Aug 15;345:577279. doi: 10.1016/j.jneuroim.2020.577279. Epub 2020 May 27.
2
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.非胸腺瘤性重症肌无力患者胸腺切除术联合泼尼松与单纯泼尼松治疗的长期疗效：MGX 随机试验的 2 年延伸。
Lancet Neurol. 2019 Mar;18(3):259-268. doi: 10.1016/S1474-4422(18)30392-2. Epub 2019 Jan 25.
3
Regulatory B cells in myasthenia gravis are differentially affected by therapies.重症肌无力中的调节性B细胞受治疗的影响存在差异。
Ann Clin Transl Neurol. 2018 Sep 22;5(11):1408-1414. doi: 10.1002/acn3.645. eCollection 2018 Nov.
4
MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis.与重症肌无力胸腺生发中心异位相关的 microRNA 和 mRNA 表达。
PLoS One. 2018 Oct 11;13(10):e0205464. doi: 10.1371/journal.pone.0205464. eCollection 2018.
5
Myasthenia gravis: from autoantibodies to therapy.重症肌无力：从自身抗体到治疗。
Curr Opin Neurol. 2018 Oct;31(5):517-525. doi: 10.1097/WCO.0000000000000596.
6
Advances in autoimmune myasthenia gravis management.自身免疫性重症肌无力的治疗进展。
Expert Rev Neurother. 2018 Jul;18(7):573-588. doi: 10.1080/14737175.2018.1491310. Epub 2018 Jul 4.
7
Thymus involvement in early-onset myasthenia gravis.胸腺瘤与早发性重症肌无力。
Ann N Y Acad Sci. 2018 Jan;1412(1):137-145. doi: 10.1111/nyas.13519. Epub 2017 Nov 10.
8
Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases.雌激素介导的自身免疫调节因子（AIRE）下调影响自身免疫性疾病中的性别差异。
J Clin Invest. 2016 Apr 1;126(4):1525-37. doi: 10.1172/JCI81894. Epub 2016 Mar 21.
9
Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-α.重症肌无力胸腺中 Treg 细胞和 Tconv 细胞均存在缺陷：IL-17 和 TNF-α的作用。
J Autoimmun. 2014 Aug;52:53-63. doi: 10.1016/j.jaut.2013.12.015. Epub 2014 Jan 7.
10
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes.不同亚型重症肌无力的发病机制中胸腺的不同作用。
Autoimmun Rev. 2013 Jul;12(9):875-84. doi: 10.1016/j.autrev.2013.03.007. Epub 2013 Mar 25.
Zotero 插件